ADVM
Adverum Biotechnologies (ADVM)
$74
About Adverum Biotechnologies (ADVM)
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.
Details
Daily high
$4.89
Daily low
$4.61
Price at open
$4.61
52 Week High
$29.70
52 Week Low
$4.61
Market cap
98.6M
Dividend yield
0.00%
Volume
276,094
Avg. volume
236,539
P/E ratio
-.79
Adverum Biotechnologies News
Details
Daily high
$4.89
Daily low
$4.61
Price at open
$4.61
52 Week High
$29.70
52 Week Low
$4.61
Market cap
98.6M
Dividend yield
0.00%
Volume
276,094
Avg. volume
236,539
P/E ratio
-.79